|
WO2019229185A1
|
|
Novel antimicrobial proteins
|
|
WO2019229184A1
|
|
Novel antimicrobial fusion proteins
|
|
AU2017360064A1
|
|
New antimicrobial agents against staphylococcus aureus
|
|
MX2019004439A
|
|
New antimicrobial agents against enterococcus bacteria.
|
|
CN109072211A
|
|
The antibacterial agent of anti-salmonella
|
|
EP3129044A1
|
|
Pharmaceutical composition against chronic bacterial infections
|
|
WO2015121443A1
|
|
Antimicrobial agents
|
|
EP3068878A1
|
|
Modified el188 endolysin sequence
|
|
EP3068877A1
|
|
Modified kz144 endolysin sequence
|
|
WO2015070911A1
|
|
Modified kz144 endolysin sequence
|
|
WO2015070912A1
|
|
Modified el188 endolysin sequence
|
|
WO2014001571A1
|
|
Composition for use in mycobacteria diagnosis
|
|
EP2679232A1
|
|
Composition for use in Mycobacteria vaccination
|
|
EP2679677A1
|
|
Composition for use in Mycobacteria therapy
|
|
US2014120074A1
|
|
Antimicrobial agents
|
|
AU2011247584A1
|
|
Method of reducing biofilms
|
|
EP2468856A1
|
|
Antimicrobial Agents
|
|
SI2445515T1
|
|
Antimicrobial agents
|
